- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- omniome.com
- Total Funding
- $133.0M
- Last Round
- $13.0M Extension RoundJan 2020
- Rounds
- 3
- Acquired by
- PacBioSep 2021
About
Omniome developed a proprietary short-read DNA sequencing platform based on Sequencing by Binding (SBB) chemistry. Acquired by PacBio in September 2021 for ~$800 million.
Summary
Omniome is a Biotech company based in San Diego, United States, founded in 2013. It has raised $133.0M in total across 3 rounds, most recently a $13.0M Extension Round round in Jan 2020. Investors include Decheng Capital, Pacific Biosciences and Madrone Capital Partners.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2021
Sign up to see all 4 rounds
Extension Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/omniome"><img src="https://indexed.vc/api/badge/company/omniome" alt="Omniome on Indexed.vc" width="260" height="76" /></a>